Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.

about

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.

Item

http://www.wikidata.org/entity/Q55023905

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sites of recurrent disease and ...... reated with radiochemotherapy.

@en

Sites of recurrent disease and ...... reated with radiochemotherapy.

@nl

type

Item

label

Sites of recurrent disease and ...... reated with radiochemotherapy.

@en

Sites of recurrent disease and ...... reated with radiochemotherapy.

@nl

prefLabel

Sites of recurrent disease and ...... reated with radiochemotherapy.

@en

Sites of recurrent disease and ...... reated with radiochemotherapy.

@nl

P1476

Sites of recurrent disease and ...... reated with radiochemotherapy.

@en

P2093

Antje Sommerer

http://www.w3.org/2001/XMLSchema#string

Calogero Gumina

http://www.w3.org/2001/XMLSchema#string

Chiara Valentini

http://www.w3.org/2001/XMLSchema#string

Daniel Zips

http://www.w3.org/2001/XMLSchema#string

Esther G C Troost

http://www.w3.org/2001/XMLSchema#string

Rebecca Bütof

http://www.w3.org/2001/XMLSchema#string

Steffen Appold

http://www.w3.org/2001/XMLSchema#string

Steffen Löck

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Current clinical trials testing the combination of immunotherapy with radiotherapy.

Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.

Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer

Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.

Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer.

P304

36-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CTRO.2017.09.010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Baumann

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29594227

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5862679

http://www.w3.org/2001/XMLSchema#string